• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Patient-physician language concordance linked to improved glycemic control

byJames EnglandandAnees Daud
January 25, 2017
in Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. For Latino patients with limited-English proficiency (LEP), changing from language-discordant to language-concordant primary care physician was associated with improved rates of glycemic and low-density-lipoprotein (LDL) control.

2. Most patients who switched physicians underwent improvement in glycemic, cholesterol, and blood pressure control regardless of language status.

Evidence Rating Level: 2 (Good)       

Study Rundown: In the United States, many of the 50 million Latinos may have limited English proficiency (LEP), which adds barriers to communication and care. In previous studies, LEP Latinos with diabetes have improved rates of anti-glycemic medication adherence and glycemic control when receiving care from a language-concordant primary care physician (PCP). The current study is an observation of LEP Latino diabetic patients undergoing PCP change to examine differences in glycemic, cholesterol, and blood pressure control based on patient-physician language concordance/discordance.

In the study cohort of LEP Latinos who underwent a change in PCP, language was listed as a reason for 30% of those who switched from discordant to concordant pairings. Overall, most patients after a PCP switch had improvements in glycemic, cholesterol, and blood pressure control. However, improvement in glycemic control was more substantial amongst the group of patients who changed from a language-discordant to language-concordant PCP. The same was seen in improvement of LDL. The strength of the study included appropriate pre- and post-change data, and the reasons for PCP changes. The main limitations of the study were the relatively short follow up period, and the lack of data about the extent of language comprehension for each patient.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Language Concordance, Interpersonal Care, and Diabetes Self-Care in Rural Latino Patients

RELATED REPORTS

Faricimab may improve visual acuity in patients with diabetic macular edema

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

In-Depth [retrospective cohort]: This study included patients from the Kaiser Permanente Northern California Diabetes Registry who self-identified as Latino with a preferred language as Spanish and switched PCPs at least once during the study period of 2007 to 2013. Patients were included if they were empaneled with pre- and post-switch physicians for 12 months, and had continuous membership, drug benefits, and physician language data available. PCPs were identified as Spanish speaking either through self-identification or through billing codes for bilingual physicians. Outcomes included good glycemic control (HbA1c <8%), poor glycemic control (HbA1c >9%), LDL control (<100 mg/dL), and systolic blood pressure control (<140 mm Hg).

A total of 1605 LEP Latinos were included in the study. Patients who switched from language-discordant to language-concordant PCPs cited language as the reason more often (30% vs. 9%). All groups (discordant to discordant, discordant to concordant, concordant to concordant, concordant to discordant) experienced improved glycemic control after switching. LEP Latinos undergoing discordant to concordant switch had the greatest improvement with 10% (p = 0.01) net increase in good glycemic control; while concordant to discordant pairings had no significant improvement in control. Control of LDL was improved for both discordant to concordant (9% increased, 95%CI 1-17%) and concordant to discordant (15%, 95%CI 7-24%) pairings.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetes mellituslatino
Previous Post

Diabetic medication non-adherence more common in Latino patients

Next Post

Recombinant vesicular stomatitis virus vaccine elicits anti-Ebola seroconversion

RelatedReports

Blindness and visual impairment decreasing worldwide
Chronic Disease

Faricimab may improve visual acuity in patients with diabetic macular edema

March 8, 2022
Insulin costs rose exponentially, regardless of formulation or patent
Cardiology

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

February 9, 2022
Cardiology

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

January 11, 2022
#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
StudyGraphics

#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes

December 2, 2021
Next Post
Concomitant HPV vaccine administration equivalent to staggered schedule

Recombinant vesicular stomatitis virus vaccine elicits anti-Ebola seroconversion

AAP addresses neonatal pain prevention

No difference between therapeutic hypo- and normo-thermia with in-hospital cardiac arrest in children

Molecular testing for Clostridium difficile may not predict disease activity

Bezlotoxumab associated with lower recurrence of C. difficile infection: The MODIFY I and II trials

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.